Mass Spectrometry Imaging Market Report 2026

Mass Spectrometry Imaging Market Overview

• Mass Spectrometry Imaging market size has reached to $2.88 billion in 2025 • Expected to grow to $4.43 billion in 2030 at a compound annual growth rate (CAGR) of 9% • Growth Driver: Surge In Personalized Medicine Fueling The Growth Of The Market Due To Growing Demand For Targeted And Effective Treatments • Market Trend: Advancements In Mass Spectrometry Imaging For Enhanced Molecular Analysis And Drug Development • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Mass Spectrometry Imaging Market?

Mass spectrometry imaging (MSI) is an analytical technique that integrates mass spectrometry with imaging to map the distribution of chemical compounds in biological or material samples. It enables the visualization of molecules like lipids, proteins, and metabolites in tissue sections. MSI provides valuable molecular insights, aiding in the study of disease processes, tissue structure, and biomarker identification. Its main purpose is to connect molecular data with spatial context for a deeper understanding of biological systems. The main product types of mass spectrometry imaging are instruments, consumables, and services. Instruments refer to the devices or equipment used to perform mass spectrometry imaging, which analyze the chemical composition of samples by measuring the mass-to-charge ratio of ions. It utilizes various technologies such as matrix-assisted laser desorption or ionization (MALDI), secondary ion mass spectrometry (SIMS), desorption electrospray ionization (DESI), magnetic sector mass spectrometry, time-of-flight mass spectrometry (TOFMS) and others for several applications including proteomics, metabolomics and glycomics, among others, and is used by various end-users such as pharmaceutical and biotechnology companies, government and academic institutions, and others.

What Is The Mass Spectrometry Imaging Market Growth Forecast?

The mass spectrometry imaging market size is expected to see strong growth in the next few years. It will grow to $4.43 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to growth in precision medicine applications, increasing adoption of spatial biology approaches, rising pharmaceutical r&d investments, advancements in ai-enabled data interpretation, expansion of clinical research applications. Major trends in the forecast period include growing adoption of msi in biomarker discovery, increasing use of msi in cancer research, rising integration of advanced imaging and data analytics, expansion of high-resolution mass spectrometry systems, increasing demand for spatial omics technologies.

Global Mass Spectrometry Imaging Market Segmentation

1) By Product Type: Instruments, Consumables, Services 2) By Technology: Matrix-Assisted Laser Desorption Or Ionization (MALDI), Secondary Ion Mass Spectrometry (SIMS), Desorption Electrospray Ionization (DESI), Magnetic Sector Mass Spectrometry, Time-of-Flight Mass Spectrometry (TOFMS), Other Technologies 3) By Application: Proteomics, Metabolomics, Glycomics, Other Applications 4) By End-User: Pharmaceutical and Biotechnology Companies, Government and Academic Institutions, Other End-Users Subsegments: 1) By Instruments: High-Resolution Mass Spectrometers, Imaging Mass Spectrometers, Matrix-Assisted Laser Desorption Or Ionization Time-of-Flight System, Liquid Chromatography-Mass Spectrometry System, Quadrupole Time-of-Flight Mass Spectrometers, Tandem Mass Spectrometers 2) By Consumables: Reagents And Chemicals, Sample Preparation Kits, Mass Spectrometry Plates And Slides, Calibration Standards, Solvents And Buffers 3) By Services: Installation And Maintenance Services, Data Analysis And Software Services, Training And Support Services, Consultation And Customization Services

What Is The Driver Of The Mass Spectrometry Imaging Market?

The rising demand for personalized medicine is expected to propel the growth of the mass spectrometry imaging market going forward. Personalized medicine customizes healthcare treatments to each patient, considering their genetic makeup, environment, and lifestyle to improve effectiveness. The rise of personalized medicine is driven by genomic advancements, enabling targeted treatments based on genetic profiles, which enhance effectiveness and reduce side effects. Mass spectrometry imaging supports personalized medicine by creating detailed molecular maps of tissues, helping identify disease biomarkers, and enabling the development of targeted therapies tailored to individual patient profiles. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023 the FDA approved 16 new personalized treatments for patients with rare diseases, a significant increase from the six approved in 2022. Therefore, the rising demand for personalized medicine is driving the growth of the mass spectrometry imaging industry.

Key Players In The Global Mass Spectrometry Imaging Market

Major companies operating in the mass spectrometry imaging market are Thermo Fisher Scientific Inc., Danaher Corporation, Hitachi High-Tech Corporation, Shimadzu Corporation, Waters Corporation, Bruker Corporation, Horiba Scientific, JEOL Ltd., SCIEX, Analytik Jena AG, Standard BioTools, TOFWERK AG, Advion Inc., MassTech Inc., CovalX AG, ImaBiotech SAS, MassAnalytica LLC, Ionwerks Inc., Biognosys AG, Spectroswiss Sàrl

Global Mass Spectrometry Imaging Market Trends and Insights

Major companies operating in the mass spectrometry imaging (MSI) market are focused on developing advanced technology, such as desorption electrospray ionization, to enable more accurate and detailed molecular analysis for a wide range of applications. Desorption electrospray ionization (DESI) is an ionization method that extracts ions from surfaces in ambient conditions using a charged solvent spray. It enables direct analysis of solid samples, such as tissues, without the need for sample preparation or extraction. For instance, in June 2023, Waters Corporation, a US-based analytical laboratory instrument manufacturing company, launched a targeted imaging mass spectrometer. It enhances tissue analysis with improved sensitivity and speed. The instrument provides more precise small-molecule drug analysis, offering higher resolution in targeted imaging. It enables faster detection, streamlining biological studies. The device boosts accuracy and efficiency, significantly benefiting research processes. This innovation supports advanced drug development and biological research by providing detailed, high-quality data.

What Are Latest Mergers And Acquisitions In The Mass Spectrometry Imaging Market?

In March 2023, Agilent Technologies Inc., a US-based manufacturer of advanced analytical, research, and diagnostic solutions, acquired e-MSion for an undisclosed amount. With this acquisition, Agilent aims to improve it’s mass spectrometry tools by adding advanced electron capture dissociation (ECD) technology that would help researchers get more detailed and accurate information about complex molecules such as proteins. e-MSion is a US-based early-stage company that specializes in electron capture dissociation (ECD) technology that helps mass spectrometers analyze complex molecules more accurately.

Regional Insights

North America was the largest region in the mass spectrometry imaging market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Mass Spectrometry Imaging Market?

The mass spectrometry imaging market consists of revenues earned by entities by providing services such as quantitative analysis, molecular profiling, chemical imaging, and pathology integration. The market value includes the value of related goods sold by the service provider or included within the service offering. The mass spectrometry imaging market includes sales of specialized detectors, mass spectrometers, testing kits, and sample preparation systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Mass Spectrometry Imaging Market Report 2026?

The mass spectrometry imaging market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the mass spectrometry imaging industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.